Clinical Trial Update: NT-101 Topical Ophthalmic Solution in Patients With Wet AMD [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update for NT-101 Topical Ophthalmic Solution in patients with wet age-related macular degeneration, covering Phase 1 and Phase 2, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• NT-101 Topical Ophthalmic Solution (NT-101)

Snippet

Sponsor: NexThera Co., Ltd. | Conditions: Wet Age Related Macular Degeneration, Wet AMD | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING